|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Selling, general and administrative expense | |||||
| Other operating income (expense): | |||||
| Currency transactions, net | |||||
| Other income, net | |||||
| Corporate expense | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Gain on remeasurement of investment in TiO2 manufacturing joint venture | |||||
| Gain on remeasurement of earn-out liability | |||||
| Interest and dividend income | |||||
| Insurance settlement gain | |||||
| Marketable equity securities | |||||
| Other components of net periodic pension and OPEB cost | |||||
| Interest expense | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Net income (loss) per share - basic (in dollars per share) | |||||
| Net income (loss) per share - diluted (in dollars per share) | |||||
| Weighted average shares used in the calculation of net income (loss) per share - basic (in shares) | |||||
| Weighted average shares used in the calculation of net income (loss) per share - diluted (in shares) | |||||
Loading...